We have invented a radiation-detection catheter that can enter the organs minimally-invasively, and localize diseased tissue for biopsy or delivery of therapy.
Vulnerable (high-risk or rupture-prone)
atherosclerotic plaques (VP) represent the major cause of sudden cardiac death. the major determinant of plaque vulnerability, inflammation, does not provide a unique structural signature. Therefore structural imaging techniques have seen limited success
patients at very high risk may benefit from invasive tests that characterize the vessel wall and identify VPs. Since these lesions may be more likely to undergo transformation into an unstable lesion, identification of intense inflammation within the lesion might tilt the decision in favor of more aggressive therapeutic approach.